Anthrazykline in der adjuvanten Therapie des Mammakarzinoms

Publisher： Karger

E-ISSN： 2296-5262|23|2|7-11

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.2, 2000-05, pp. : 7-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromataseinhibitoren in der adjuvanten Therapie des Mammakarzinoms

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 45, Iss. 3, 2005-06 ,pp. : 132-136

Karger

Access to resources Recommend Favorite

Bisphosphonate in der adjuvanten Therapie des Mammakarzinoms – Pathophysiologie, Tiermodelle und erste klinische Erfahrungen

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 38, Iss. 2, 2009-03 ,pp. : 64-71

Karger

Access to resources Recommend Favorite

Wichtige Fortschritte in der adjuvanten Systemtherapie des Mammakarzinoms

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 48, Iss. 3, 2008-06 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Taxane in der primären systemischen Therapie des Mammakarzinoms

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 21-25

Karger

Access to resources Recommend Favorite

Anthrazykline in der Therapie des Ovarialkarzinoms – Vergangenheit, Gegenwart und Zukunft

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 46-52

Karger

Access to resources Recommend Favorite